The Inflation Reduction Act of 2022 improves coverage and lowers out-of-pocket costs of recommended vaccines and insulin for people with Medicare plans.

Vaccines

• Starting January 1, 2023, Medicare members with Part D drug coverage will pay nothing out-of-pocket for adult vaccines recommended by the Advisory Committee on Immunization Practices. These include the shingles and tetanus-diphtheria-pertussis (Tdap) vaccines.

Insulin/insulin products

• Medicare members will have access to insulin for no more than $35 for a month’s supply. In addition, there will be no deductibles for covered insulin products.
• The new rules for insulin coverage begin:
  • January 1, 2023, for insulin covered under Medicare Part D prescription drug plans
  • July 1, 2023, for insulin used through a traditional pump covered under Original Medicare’s durable medical equipment benefit

For more information about the Inflation Reduction Act, please visit:

CMS.gov/files/document/10522-external-faqs-about-inflation-reduction-act.pdf

For Medicare formulary (covered) drugs please visit Medicare.PacificSource.com/Search/Drug.